Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;322(1):329-338.
doi: 10.1111/imr.13302. Epub 2023 Dec 19.

Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity

Affiliations
Review

Understanding very early onset inflammatory bowel disease (VEOIBD) in relation to inborn errors of immunity

Caroline H T Hall et al. Immunol Rev. 2024 Mar.

Abstract

Inflammatory bowel diseases (IBD) are multifactorial diseases which are caused by the combination of genetic predisposition, exposure factors (environmental and dietary), immune status, and dysbiosis. IBD is a disease which presents at any age, ranging from newborns to the elderly. The youngest of the pediatric IBD population have a more unique presentation and clinical course and may have a different etiology. Very early onset IBD (VEOIBD) patients, designated as those diagnosed prior the age of 6, have distinct features which are more frequent in this patient population including increased incidence of monogenetic causes for IBD (0%-33% depending on the study). This proportion is increased in the youngest subsets, which is diagnosed prior to the age of 2. To date, there are approximately 80 monogenic causes of VEOIBD that have been identified and published. Many of these monogenic causes are inborn errors of immunity yet the majority of VEOIBD patients do not have an identifiable genetic cause for their disease. In this review, we will focus on the clinical presentation, evaluation, and monogenic categories which have been associated with VEOIBD including (1) Epithelial cell defects (2) Adaptive immune defects, (3) Innate Immune/Bacterial Clearance and Recognition defects, and (4) Hyperinflammatory and autoinflammatory disorders. We will highlight differential diagnosis of VEOIBD presentations, as well as evaluation and treatment, which will be helpful for those who study and care for VEOIBD patients outside of the pediatric gastroenterology field. This is a fast-moving field of research which has grown significantly based on knowledge that we gain from our patients. These scientific findings have identified novel mucosal biology pathways and will continue to inform our understanding of gastrointestinal biology.

Keywords: T cells; autoinflammatory process; epithelial cells; inflammatory bowel disease; monogenic; very early onset inflammatory bowel disease.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

No competing interests.

Figures

FIGURE 1
FIGURE 1
Evaluation of patients with very early onset inflammatory bowel disease. Created with Biorender.com.
FIGURE 2
FIGURE 2
Genes involved in monogenic causes of very early onset inflammatory bowel disease. Created with Biorender.com.

Similar articles

Cited by

References

    1. Herzog D, Fournier N, Buehr P, et al. Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients. Eur J Gastroenterol Hepatol. 2017;29:926–931. - PubMed
    1. Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007.e3. - PMC - PubMed
    1. Uhlig HH, Charbit-Henrion F, Kotlarz D, et al. Clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease: a position paper from the Paediatric IBD Porto Group of European Society of Paediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2021;72:456–473. - PMC - PubMed
    1. Collen LV, Kim DY, Field M, et al. Clinical phenotypes and outcomes in monogenic versus non-monogenic very early onset inflammatory bowel disease. J Crohns Colitis. 2022;16:1380–1396. - PMC - PubMed
    1. Ouahed J, Spencer E, Kotlarz D, et al. Very early onset inflammatory bowel disease: a clinical approach with a focus on the role of genetics and underlying immune deficiencies. Inflamm Bowel Dis. 2020;26:820–842. - PMC - PubMed